We implement state-of-the-art biotechnology and genomic approaches that drive companies to excel in the genetic improvement of their biological assets. By integrating genetic data from the species of interest, we decipher the genetic architecture of profitable traits. This enables us to create varieties that are tailored to your business needs.
Small ruminants are important cultural and economic livestock in many countries around the world. We work with farm associations and to develop and apply cutting-edge technologies to increase the genetic value of landrace in Spain and other Mediterranean countries.
We are implementing new hemp genetic research and development in our facilities in Canada. We have submitted the first Plant Patent Application at the U.S. Patent and Trademark Office (US Department of Commerce) without botanical description of the strain, just submitting its whole genome sequence.
iLabSystems is the human health branch of GCGenomics. In iLabSystems we help companies and research organizations to analyze genomic and epigenomics data, design the statistical approach to clinical research projects, develop health economic and epidemiological models and apply machine learning.
We implement state-of-the-art biotechnology and genomic approaches that drive companies to excel in the genetic improvement of their biological assets. By integrating genetic data from the species of interest, we decipher the genetic architecture of profitable traits. This enables us to create varieties that are tailored to your business needs.
Small ruminants are important cultural and economic livestock in many countries around the world. We work with farm associations and to develop and apply cutting-edge technologies to increase the genetic value of landrace in Spain and other Mediterranean countries.
In 2018, the high-density AxiomTM J. regia 700K SNP genotyping array is developed and validated. This sophisticated genetic tool is available nowadays and allow us to apply genomics selection programs to adapt to news market demands in a much faster pace.
We are currently working with our partners in new assays in phytosanitary products, plant nutrients, animal feed additives. These products will help you improving the quality and profitability of your agricultural and livestock business.
In collaboration with the centro de investigaciones científicas y tecnológicas de Extremadura (CICYTEX) GCGenomics is sequencing more than one hundred cherry cultivars, many of them out of market many decades ago that provide an unprecedented phenotypic.
We are implementing new hemp genetic research and development in our facilities in Canada. We have submitted the first Plant Patent Application at the U.S. Patent and Trademark Office (US Department of Commerce) without botanical description of the strain, just submitting its whole genome sequence.
iLabSystems is the human health branch of GCGenomics. In iLabSystems we help companies and research organizations to analyze genomic and epigenomics data, design the statistical approach to clinical research projects, develop health economic and epidemiological models and apply machine learning.